Paul Lanzi leads the Mobile App, Web App and Portal team at Gilead Sciences. Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need – in therapeutic areas like HIV, hepatitis, serious respiratory, cardiovascular, and metabolic conditions, cancer and inflammation. Paul and his team deliver beautiful and useful mobile apps to Gilead’s 5,000 global employees, seeking to make the job of finding, developing and marketing treatments for major unmet medical needs just a little bit easier.
Like what you see? Make sure you're getting it all
Independent and authoritative analysis and perspective for every segment of mergers and aquisitions.